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KEYWORDS Summary  Chronic  recurrent  multifocal  osteomyelitis  (CRMO)  is  a  diagnosis  of  exclusion  pri-
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marily in  children  and  adolescents.  As  part  of  the  essential  criteria  for  the  diagnosis  of  CRMO,
multifocal lesions  must  be  identiﬁed.  We  present  the  case  of  an  11-year-old  boy  with  CRMO,
whose diagnosis  was  facilitated  by  the  use  of  whole  body  magnetic  resonance  imaging  (WBMR),
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Introduction
Chronic  recurrent  multifocal  osteomyelitis  (CRMO)  is  a  diag-
nosis  of  exclusion  characterized  by  multiple  areas  of  sterile
osteomyelitis,  which  become  symptomatic  intermittently
over  time.  Although  principally  a  disease  of  children,  it  regu-
larly  continues  to  be  symptomatic  well  into  a  person’s  20s,
and  has  been  reported  in  one  patient  of  55  years  [1,2]. CRMO
is  the  most  common  disease  process  to  involve  the  medial
third  of  the  clavicle  in  all  age  groups,  and  the  most  frequent
non-oncological  pathology  to  affect  the  clavicle  in  people
under  20  years  old  [3].  The  most  common  areas  affected
are  the  tibia,  femur,  pelvis  and  spine  [4].
The  majority  of  patients  present  with  disease  at  just
one  site,  and  occult  multifocal  lesions  are  discovered
on  subsequent  imaging,  or  recurrent  exacerbations.  How-
ever,  a  signiﬁcant  minority  of  children  with  non-bacterial
osteomyelitis  may  have  only  ever  had  a  single  lesion,  for
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hich  the  term  ‘‘chronic  nonbacterial  osteomyelitis’’  rather
han  CRMO  has  been  suggested  [5].  Therefore  in  order  to
dentify  CRMO,  the  key  diagnostic  criteria  include  identi-
ying  areas  of  sterile  chronic  osteomyelitis,  which  must  be
ultifocal.  Fritz  et  al.  described  basing  their  diagnosis  of
RMO  on  the  following  criteria:  multifocal  osseous  lesions;
ecurrence  of  signs  and  symptoms  for  at  least  6  months;
ack  of  an  identiﬁable  cause;  lack  of  response  to  antimicro-
ial  therapy  for  at  east  1  month;  and  chronic,  nonspeciﬁc
nﬂammation  consisting  of  lymphocytes,  plasma  cells,  and
istiocytes  at  histopathologic  examination  [6].  Thus  in  order
o  ﬁnd  multiple  clinically  occult  lesions  one  should  consider
ither  whole  body  magnetic  resonance  imaging  (MRI),  or
hole  body  Tc-99m  labelled  methylene  diphosphonate  (MDP)
one  scintigraphy.  We  present  a  case  of  CRMO  where  the
iagnosis  was  facilitated  by  whole  body  MRI  but  not  by  bone
cintigraphy.ase report
n  11-year-old  male  was  referred  to  our  paediatric
rthopaedic  unit  from  a peripheral  general  hospital.  The
served.
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[16].  The  sensitivity  of  MRI  for  osteomyelitis  has  beenFigure  1  Right  clavicle  lesion.
atient’s  main  symptoms  were  that  of  a  6-week  history  of
radually  increasing  right  medial  clavicle  discomfort,  with
 palpable  ﬁrm  swelling  in  that  region  (Fig.  1).  There  was
 history  of  trauma,  and  a  healing  fracture  was  the  initial
orking  diagnosis  in  the  peripheral  hospital.  The  patient’s
lavicle  continued  to  expand  both  clinically  and  on  plain
adiographs  and  he  was  referred  to  our  unit  for  a  second
pinion.  The  patient  had  a  mildly  elevated  erythrocyte  sedi-
entation  rate  (ESR)  of  18  at  his  initial  presentation.  After
nitial  investigations  were  performed,  including  plain  radio-
raphs,  computed  tomography  (CT)  and  routine  bloods,  the
orking  diagnosis  was  that  of  an  infective  osteomyelitis,
ut  non-bacterial  osteomyelitis,  CRMO,  Langerhan’s  cell  his-
iocytosis  and  unidentiﬁed  neoplasm  were  included  in  the
ifferential  diagnosis.  The  patient  had  a  bone  biopsy,  and
he  result  indicated  cell  inﬁltrate  consistent  with  chronic
steomyelitis,  but  no  bacteria  were  grown.  A  diagnosis  of
onbacterial  osteomyelitis  was  regarded  as  probable,  but
ince  it  is  a  diagnosis  of  exclusion  the  patient  was  com-
enced  on  a  6-week  course  of  oral  ﬂucloxacillin  and  fusidic
cid.
Despite  these  measures  the  patient’s  discomfort  conti-
ued  and  he  returned  to  our  unit  approximately  four  weeks
fter  his  antimicrobial  therapy  had  started.  A  whole-body
c-99m  MDP  bone  scintigraphy  was  performed  to  help  sup-
ort  a  diagnosis  of  CRMO,  but  the  only  area  of  increased
ptake  was  the  right  clavicle.  The  patient  was  commenced
n  a  non-steroidal  anti  inﬂammatory  (naproxen  sodium)  and
is  right  clavicle  discomfort  began  to  settle.  Three  weeks
ater  the  patient  re-attended  to  us  as  he  had  an  exacerbation
f  his  clavicle  discomfort.  Repeat  plain  radiographs  indi-
ated  that  the  right  clavicle  lesion  was  continuing  to  expand.
 whole-body  MRI  was  performed.  Coronal  STIR  sequences
n  ﬁve  segments  were  obtained.  In  addition  to  the  clavicu-
ar  lesion,  the  MRI  showed  an  unexpected  area  of  increased
ignal  intensity  in  the  left  acetabulum  (Fig.  2).  The  patient
ad  no  symptoms  in  the  left  lower  extremity,  and  had  no  his-
ory  of  injury  or  symptoms  in  this  area.  The  ﬁnding  allowed  a
iagnosis  of  CRMO  to  be  made,  given  that  the  clinical  criteria
entioned  in  the  introduction  had  already  been  fulﬁlled  [6].
he  patient  was  given  a  2-week  course  of  an  oral  corticos-
eroid  and  long-term  course  of  naproxen.  At  six  month  follow
p,  the  patient’s  symptoms  were  well  controlled,  with  mild
hort-lived  intermittent  episodes  of  clavicle  discomfort.  His
c
s
aFigure  2  Left  acetabular  lesion  on  MRI.
eft  hip  was  never  symptomatic.  The  nature  of  CRMO  is  such
hat  his  symptoms  could  recur  sporadically.
iscussion
he  diagnosis  of  CRMO  is  essentially  one  of  exclusion.  It
s  important  however  to  establish  a  valid  conclusion  as
oon  as  it  is  feasible,  in  order  to  prevent  repeated  courses
f  antibiotics  and  biopsies.  At  any  time  the  number  of
esions  can  vary  from  one  to  18,  with  the  majority  being
symptomatic  [7,8]. CRMO  has  been  hypothesized  to  be  an
uto-inﬂammatory  syndrome  [9].  There  have  been  reported
ssociations  with  multiple  autoimmune  diseases,  including
eripheral  arthritis,  inﬂammatory  bowel  disease,  psoriasis,
acro-iliitis  and  a  juvenile  form  of  seronegative  spondy-
oarthropathy  [10].
In 1989,  Majeed  et  al.  reported  a  consanguineous  family
ith  CRMO  and  Sweet  syndrome,  which  contrasted  with  the
sual  sporadic  nature  of  CRMO  [11]. These  Majeed  syndrome
amilies  have  demonstrated  homozygous  mutations  of  the
PIN2  gene  present  in  chromosome  18p11,  which  may  ten-
atively  suggest  a  link  between  lipid  metabolism  and  these
nﬂammatory  pathologies  [12,13].  A  condition  similar  to
RMO  has  been  seen  in  mice,  known  as  chronic  multifocal
steomyelitis  (CMO).  Mouse  CMO  has  been  shown  to  be  con-
eyed  in  an  autosomal  recessive  manner.  The  PSTPIP2  gene
n  the  mouse  chromosome  18  has  been  recognized  as  the
ausative  gene  for  CMO  [14]. However,  the  PSTPIP2  gene
esides  on  chromosome  18q12  in  humans,  while  the  respon-
ible  gene  locus  for  sporadic  CRMO  cases  is  thought  to  dwell
n  chromosome  18q21-22,  so  it  is  unclear  if  the  PSTPIP2  gene
an  be  a  causative  agent  in  humans  [15].
The differential  diagnosis  for  CRMO  includes  infec-
ion,  neoplastic  lesions  and  occasionally  trauma.  Neoplastic
ype  lesions,  which  CRMO  mimic  include  Ewing  sarcoma,
euroblastoma  metastasis,  osteosarcoma,  leukemia,  lym-
homa,  Langerhans  cell  histiocytosis,  eosinophilic  gra-
uloma,  osteoid  osteoma,  and  osteoblastoma.  Chronic
steomyelitis  can  also  have  a  similar  appearance  to  CRMO
10].
The  standard  approach  when  investigating  possible
steomyelitis  with  bone  scintigraphy,  is  to  perform  a
hree-phase  scan  using  99m  Technetium-labeled  methylene
iphosphonate  (MDP).  The  positive  uptake  on  all  three
hases  is  sensitive  for  osteomyelitis  (sensitivity  73%  to  100%)ommonly  reported  as  being  between  82%  and  100%,  and
peciﬁcity  between  75%  and  96%  [17,18]. El-Maghraby  et  al.
rgue  that  in  the  setting  of  CRMO,  the  imaging  agent  ‘‘67
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Gallium-citrate’’  can  increase  speciﬁcity  when  used  in  com-
bination  with  Tc-99m  MDP,  but  it  is  not  clear  if  there  is  an
increased  sensitivity  [16]. Gallium  is  also  associated  with
a  signiﬁcantly  higher  radiation  dose  and  is  thus  used  with
caution  in  children.  In  this  case,  the  new  acetabular  lesion
was  undetectable  on  the  bone  scan.  Reasons  for  missing  the
second  lesion  here  include  the  possibility  that  the  normal
physiological  uptake  in  the  acetabular  physis  masked  the
subtle  marrow  changes  visible  on  the  MRI.  Bone  scintigra-
phy  relies  on  osteoblast  activity,  seen  in  infection,  healing
fractures  and  metastases  but  not  in  other  conditions,  such
as  myeloma.  On  the  other  hand,  MR  will  detect  ‘‘marrow’’
inﬂammation,  with  or  without  the  presence  of  osteoblast
activity.  Fritz  et  al.  argue  that  MR  imaging  has  the  advantage
over  bone  scanning  of  better  demonstrating  lesions  conﬁned
to  the  marrow  [6].  In  this  case  the  occult  lesion  was  con-
ﬁned  to  the  acetabular  marrow.  MR  imaging  is  useful  both
for  determining  the  extent  of  disease  and  for  surveillance
in  CRMO.  During  the  active  phase  of  the  disease,  MR  ima-
ging  shows  typical  ﬁndings  of  marrow  edema,  which  appears
hypointense  on  T1-weighted  images  and  hyperintense  on
T2-weighted  images.  Whole-body  MRI  uses  fat-saturated
sequences  to  signiﬁcantly  reduce  or  null  the  signal  com-
ing  from  normal  fatty  marrow,  thereby  accentuating  any
high  signal  within  the  marrow.  Associated  periostitis,  soft
tissue  inﬂammation,  and  transphyseal  disease  can  also  be
visualized  on  MRI  [19,20].
The  advantages  of  whole  body  MRI  (WBMR)  over  bone
scintigraphy  include  the  lack  of  any  ionizing  radiation,
quicker  completion  time,  ability  to  detect  subtle  lesions  ear-
lier  and  that  associated  soft  tissue  pathologies  can  be  shown
more  readily,  which  would  be  otherwise  missed  by  scintigra-
phy.  MRI  has  become  the  established  standard  of  reference
for  many  diseases  that  involve  bone  marrow  [6],  although
Khanna  et  al.  caution  against  the  expense  of  whole  body  MRI,
particularly  if  a  general  anaesthetic  is  required  in  younger
children  [4].
Some  disadvantages  are  that  rib  and  skull  lesions  can  be
missed  due  to  relatively  large  slice  thickness.  The  lungs  are
also  not  well  visualized  due  to  motion  artefact.  Age-related
paediatric  bone  marrow  changes  could  also  cause  diagnostic
difﬁculty  to  the  untrained  eye  [21,22].
Because  of  the  relative  rarity  of  CRMO,  there  have  been
no  randomized  trials  to  elucidate  the  best  treatment.  NSAIDs
have  been  reported  to  provide  symptomatic  relief  in  up
80%  of  patients  [5,23—25],  although  up  to  50%  of  patients
continue  to  get  symptoms  or  relapses  despite  NSAID  medi-
cation  [5].  Corticosteroids  have  been  used  for  short-term
treatment  of  exacerbations  [5,23—25],  but  side  effects  can
preclude  long-term  use.  Sulfasalazine  and  methotrexate
have  been  used  with  successful  resolution  of  symptoms
[5,25].  In  children  who  don’t  respond  well  to  these  treat-
ment  modalities,  there  have  also  been  encouraging  reports
relating  to  TNF- inhibitors  and  intravenous  biphosphonates
[24,26,27]. Surgical  treatment  is  usually  reserved  to  biopsy,
although  there  are  anecdotal  accounts  of  symptom  improve-
ment  following  curettage.  Prognosis  is  usually  good  in  the
long  term.  French  and  Canadian/Australian  cohort  reviews
reported  average  disease  duration  of  5.3  and  5.6  years
respectively  [25,28].  In  the  Canadian/Australian  cohort  as
many  as  50%  developed  bony  deformities  they  regarded
as  either  cosmetically  or  functionally  deleterious  [28]. A
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inority  of  sufferers  continued  to  have  chronic  pain,  which
as  usually  associated  with  ongoing  disease  activity  well
eyond  the  average  5-year  symptomatic  period.
In  relation  to  this  case  report  and  our  difﬁculty  diagnosing
RMO,  we  would  recommend  that  whole-body  MRI  should
onsidered  when  possible,  as  part  of  the  diagnostic  workup.
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